Joycelynne M. Palmer, Joyce C. Niland, Marilyn Slovak, Wendy Mack, Susan Preston-Martin, David S. Snyder. Blood/Marrow Transplantation for treatment of Chronic Myeloid Leukemia Identifying Predictors of Cytogenetic Relapse and Death. VDM Verlag Dr. Müller Aktiengesellschaft & Co. KG Dudweiler Landstr. 125 a, 66123 Saarbrücken, Germany, 2008.

David S. Snyder, M.D., Joycelynne Palmer, Ph. D., Anthony S. Stein, M.D., Vinod Pullarkat, M.D., Firoozeh Sahebi, M.D., Sandra Cohen, M.D., Nayana Vora, M.D., Karl Gaal, M.D., Ryo Nakamura, M.D., and Stephen J. Forman, M.D.: Allogeneic Hematopoietic Cell Transplantation Following Reduced-Intensity Conditioning for Treatment of Myelofibrosis.: Biology of Blood and Marrow Transplantation. 12:1161-1168, 2006.

Paul A. Carpenter, David S. Snyder, Mary E. Flowers, Jean E. Sanders, Theodore Gooley, Paul J. Martin, Frederick R. Applebaum, Jerald P. Radich: Prophylactic administration of Imatinib after Hematopoietic Cell Transplantation for high-risk Philadelphia chromosome-positive leukemia.: Blood, Accepted, 2006.

Vivian G. Oehler, Ted Gooley, David S. Snyder, Laura Johnston, Allen Lin, Carrie C. Cummings, Su Chu, Ravi Bhatia, Stephen J. Forman, Robert S. Negrin, Frederick R. Applebaum, and Jerald P. Radich: The Effects of Imatinib Mesylate Treatment before Allogeneic Transplant for Chronic Myeloid Leukemia. BLOOD, Blood First Edition Paper, prepublished online October 24, 2006.

Wu Y, Slovak M, Snyder D, Arber D. Coexistence of Inversion 16 and the Philadelphia Chromosome in Acute and Chronic Myeloid Leukemias. Am J Clin Pathol. 125:260-266, 2006.

Zain J, Smith E, Palmer J, Parker P, Snyder DS, Rodriguez R, Nakamura R, Pullarkat V, Al-Kadhimi Z, Rosenthal J, Smith D. The Use of Daclizumab for Treatment of Steroid Refractory Acute GVHD. A City of Hope Experience. Journal of Clinical Oncology. 23: 6672, 2005.

Nademanee A, Forman SJ, Molina A, Fung H, Smith D, Dagis A, Kwok C, Yamauchi D, Anderson AL, Falk P, Krishnan A, Kirschbaum M, Kogut N, Nakamura R, O'Donnell M, Parker P, Popplewell L, Pullarkat V, Rodriguez R, Sahebi F, Smith E, Snyder DS, Stein A, Spielberger R , Zain J, White C, Raubitschek A. A Phase 1/2 Trial of High-Dose Yttrium-90-Ibritumomab Tiuxetan in Combination with High-Dose Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Patients with Poor-Risk or Relapsed Non-Hodgkin Lymphoma. Blood.  106: 2896-2902, 2005.

Lopez F, Parker P, Nademanee A, Rodriguez R, Al-Kadbimi Z, Bhatia R, Cohen S, Falk P, Fung H, Kirschbaum M, Krishnan A, Kogut N, Molina A, Nakamura R, O'Donnell M, Popplewell L, Pullarkat V, Rosenthal P, Sahebi F, Smith E, Snyder DS, Somlo G, Spielberger R, Stein A, Sweetman R, Zain J, Forman SJ. Efficacy of Mycophenolate Mofetil in the Treatment of Chronic Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation. 11:307-313, 2005.

O’Brien S, Berman E, Bhalla K, Copelan EA, Devetten MP, Emanuel PD, Erba HP, Greenberg PL, Moore JO, Przepiorka D, Radich JP, Schilder RJ, Shami P, Smith BD, Snyder DS, Soiffer RJ, Tallman MS, Talpaz M, Wetzler M. Chronic Myelogenous Leukemia. Journal of National Comprehensive Cancer Network. 3:732-755, 2005.

Chu S, Xu H, Shah NP, Snyder DS, Forman SJ, Sawyers CL, Bhatia R. Detection of BCR-ABL Kinase Mutations in CD34+ cells from Chronic Myelogenous Leukemia Patients in Complete Cytogenetic Remission on Imatinib Mesylate Treatment. Blood. 105:2093-2098, 2005.

Oehler VG, Radich JP, Storer B, Blume KG, Chauncey T, Clift R, Snyder DS, Forman SJ, Flowers MED, Martin P, Guthrie KA, Negrin RS, Appelbaum FR, Bensinger W. Randomized Trial of Allogeneic Related Bone Marrow Transplantation Versus Peripheral Blood Stem Cell Transplantation for Chronic Myeloid Leukemia. Biology of Blood and Marrow Transplantation. 11:85-92, 2005.

Snyder DS, Stein AS, O’Donnell MR, Gaal K, Slovak ML, Forman SJ. Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Secondary to Chemoradiotherapy for Ewing’s Sarcoma. A Report of Two Cases and a Review of the Literature. American Journal of Hematology 78:74-78 (2005).

Snyder DS: Allogeneic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation 6:597-603, 2000.

Wu Y, Yu L, McMahon R, Rossi JJ, Forman SJ, Snyder DS: Inhibition of bcr abl Oncogene Expression By Novel Deoxyribozymes (DNAzymes). Human Gene Therapy 1999; 10(17)

Snyder DS, Nademanee AP, O'Donnell MR, Parker PM, Stein AS, Margolin K, Somlo G, Molina A, Spielberger R, Kashyap A, Fung H, Vora N, Slovak ML, Dagis A, Negrin RS, Amylon MD, Blume KG, Forman SJ: Allogeneic Bone Marrow Transplantation for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: Long Term Follow up. Leukemia 1999.

Snyder DS, Nademanee AP, O'Donnell MR, Parker PM, Stein AS, Margolin K, Somlo G, Molina A, Spielberger R, Kashyap A, Fung H, Vora N, Slovak ML, Niland J, Palmer J, Negrin RS, Amylon MD, Blume KG, Forman, SJ: Allogeneic Bone Marrow Transplantation for BCR ABL Positive Acute. Lymphoblastic Leukemia. Acute Leukemia VIII Proceedings, Publisher Springer Verlag, Heidelberg, Germany 1999.

Khalidi HS, Brynes, RK, Medeiros LJ, Chang KL, Slovak ML, Snyder DS, Arber DA: The Immunophenotype of Blast Transformation of Chronic Myelogenous Leukemia: A High Frequency of Mixed Lineage Phenotype In "Lymphoid" Blasts and a Comparison Of Morphologic, Immunophenotypic, and Molecular Findings. Modern Pathology 1998 Dec; 11(12): 1211 21.

Snyder DS, Wu Y, McMahon R, Lijuan Y, Rossi JJ, and Forman SJ: Ribozyme Mediated Inhibition of Philadelphia Chromosome Positive Acute Lymphobla§tic Leukemia Cell Line Expressing the P 190 BCR ABL Oncogene. Biology of Blood and Marrow Transplantation 3:179 186, 1997.

Snyder DS, Wu Y, McMahon R, Lijuan Y, Rossi JJ, and Forman SJ: Ribozyme Mediated Inhibition of a Philadelphia¬Chromosome Positive Acute Lymphoblastic Leukemia Cell Line Expressing the P190 BCR ABLOncogene. Biology of Blood and Marrow Transplantation 3:179-186, 1997.


This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 12/08.